Skip to main content
. 2023 Apr 12;16(10):1644–1655. doi: 10.1093/ckj/sfad077

Table 3:

Cox regression analyses for determinants of MN recurrence after transplantation*.

Variable Univariate HR (95% CI) P value Multivariate HR [95% CI] P value
Age at transplantation, per year 1.06 (1.01–1.10) 0.011 1.02 (0.98–1.07) 0.310
Sex
 Male 1.00 (ref.)
 Female 1.68 (0.48–5.87) 0.418 NS
Hypertension
 No 1.00 (ref.)
 Yes 5.31 (0.70–40.43) 0.107 NS
Time to kidney failure on native kidneys, per year 0.98 (0.88–1.08) 0.635 NS
Time on dialysis, per month 1.00 (0.98–1.01) 0.604 NS
KT decade
 1991–2000 1.00 (ref.)
 2001–2010 6.20 (0.68–56.16) 0.105
 2011–2020 11.34 (1.29–99.95) 0.029 3.03 (1.02–8.97) 0.046
Preemptive KT
 No 1.00 (ref.)
 Yes 2.91 (0.81–10.40) 0.100 NS
Type of donor
 DBD 1.00 (ref.)
 DCD 0.95 (0.20–4.49) 0.944
 Living donor 1.51 (0.43–5.33) 0.518
 Living related donor 1.07 (0.24–4.78) 0.925 NS
HLA-A/B/DR mismatch
 ≤3 1.00 (ref.)
 >3 1.03 (0.38–2.77) 0.949 NS
HLA-DRB1*03 0.47 (1.61–1.34) 0.157 NS
CIT, per hour 1.01 (0.94–1.08) 0.758 NS
Induction therapy
 None 1.00 (ref.)
 Basiliximab/Daclizumab 2.28 (0.74–7.01) 0.151
 ATG/ALG/ATGAM 0.48 (0.10–2.40) 0.370 NS
Maintenance with CCT + CNI + AMF
 No 1.00 (ref.)
 Yes 1.90 (0.23–16.01) 0.555 NS
Steroid free/early steroid withdrawal
 No 1.00 (ref.)
 Yes 0.41 (0.05–3.30) 0.403 NS
DGF
 No 1.00 (ref.)
 Yes 0.89 (0.32–2.41) 0.818 NS
Rejection episode during follow-up
 No 1.00 (ref.)
 Yes 1.73 (0.61–4.93) 0.307 NS
eGFR 3 months after KT, per ml/min/1.73 m2 1.00 (0.97–1.02) 0.743 NS
Proteinuria 3 months after KT, per g/24 h 7.55 (2.49–22.86) <0.001 4.28 (1.47–12.48) 0.008

* Number of events: 18